Zobrazeno 1 - 10
of 305
pro vyhledávání: '"Jean-Paul Behr"'
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 13, Iss , Pp 483-492 (2018)
We report the evaluation of 18-mer 2′-O-methyl-modified ribose oligonucleotides with a full-length phosphorothioate backbone chemically conjugated at the 5′ end to the oligospermine units (Sn-: n = 5, 15, 20, 25, and 30 [number of spermine units]
Externí odkaz:
https://doaj.org/article/c3f230b50ab44ad0bb3ef0b0af083011
Autor:
A. S. Borovik
Publikováno v:
Journal of the American Chemical Society. 119:5770-5770
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 13, Iss, Pp 483-492 (2018)
Molecular Therapy-Nucleic Acids
Molecular Therapy-Nucleic Acids, Elsevier, 2018, 13, pp.483-492. ⟨10.1016/j.omtn.2018.09.027⟩
Molecular Therapy. Nucleic Acids
Molecular Therapy-Nucleic Acids
Molecular Therapy-Nucleic Acids, Elsevier, 2018, 13, pp.483-492. ⟨10.1016/j.omtn.2018.09.027⟩
Molecular Therapy. Nucleic Acids
We report the evaluation of 18-mer 2′-O-methyl-modified ribose oligonucleotides with a full-length phosphorothioate backbone chemically conjugated at the 5′ end to the oligospermine units (Sn-: n = 5, 15, 20, 25, and 30 [number of spermine units]
Autor:
Jean-Paul Behr
Publikováno v:
CHIMIA, Vol 51, Iss 1-2 (1997)
Several non-permanent polycations possessing substantial buffering capacity below physiological pH, such as lipopolyamines and polyethylenimines, are efficient transfection agents per se, i.e. without the addition of lysosomotropic bases, or cell tar
Externí odkaz:
https://doaj.org/article/d11194c572e546c7803f05d07a039d80
Publikováno v:
Molecular Pharmaceutics
Molecular Pharmaceutics, American Chemical Society, 2016, 13 (8), pp.2718-2728. ⟨10.1021/acs.molpharmaceut.6b00309⟩
Molecular Pharmaceutics, American Chemical Society, 2016, 13 (8), pp.2718-2728. ⟨10.1021/acs.molpharmaceut.6b00309⟩
Oligospermine-siRNA conjugates are able to induce efficient luciferase gene silencing upon carrier-free transfection. These conjugates are readily accessible by a versatile automated chemistry that we developed using a DMT-spermine phosphoramidite re
Publikováno v:
Le Monde. 5/30/2009, p22. 0p.
Autor:
Jean-Paul Behr, Marc Nothisen, Jean-Serge Remy, Mitsuharu Kotera, Jérémy Bagilet, Phanélie Perche
Publikováno v:
Journal of Controlled Release. 170:92-98
Despite its considerable interest in human therapy, in vivo siRNA delivery is still suffering from hurdles of vectorization. We have shown recently efficient gene silencing by non-vectorized cationic siRNA. Here, we describe the synthesis and in vitr
Autor:
Tianzhu Yu, Xiaoxuan Liu, Anne‐Laure Bolcato‐Bellemin, Yang Wang, Cheng Liu, Patrick Erbacher, Fanqi Qu, Palma Rocchi, Jean‐Paul Behr, Ling Peng
Publikováno v:
Angewandte Chemie. 124:8606-8612
Autor:
Patrick Erbacher, Anne-Laure Bolcato-Bellemin, Marie-Elise Bonnet, Jean-Paul Behr, Gaëlle Creusat
Publikováno v:
Proceedings of the National Academy of Sciences. 104:16050-16055
siRNA delivery to cells offers a convenient and powerful means of gene silencing that bypasses several barriers met by gene delivery. However, nonviral vectors, and especially polymers, form looser complexes with siRNA than with plasmid DNA. As a con
Publikováno v:
Journal of the American Chemical Society. 128:10763-10771
Oligonucleotide delivery is a crucial issue for therapeutical purposes and is often addressed by conjugation to short cationic peptides although with controversial results. To further examine this mechanism, a 15-mer anionic oligonucleotide was conju